University of Rhode Island

DigitalCommons@URI
Open Access Master's Theses
2016

The Effect of Caffeine Supplementation on Muscular Endurance in
Recreationally Active College Age Males
Mark Gauvin
University of Rhode Island, mark_gauvin@my.uri.edu

Follow this and additional works at: https://digitalcommons.uri.edu/theses

Recommended Citation
Gauvin, Mark, "The Effect of Caffeine Supplementation on Muscular Endurance in Recreationally Active
College Age Males" (2016). Open Access Master's Theses. Paper 866.
https://digitalcommons.uri.edu/theses/866

This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information,
please contact digitalcommons@etal.uri.edu.

THE EFFECT OF CAFFEINE SUPPLEMENTATION ON MUSCULAR
ENDURANCE IN RECREATIONALLY ACTIVE COLLEGE AGE MALES

BY
MARK GAUVIN

A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
MASTER OF SCIENCE
IN
NUTRITION AND FOOD SCIENCES

UNIVERSITY OF RHODE ISLAND
2016

MASTER OF SCIENCE THESIS
OF
MARK R. GAUVIN

APPROVED:
Thesis Committee:
Major Professor

Kathleen Melanson
Ingrid Lofgren
Disa Hatfield
Nasser H. Zawia
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2016

ABSTRACT
Objective: Caffeine is a drug consumed regularly by approximately 90% of adults
worldwide, primarily due to its ability to reduce fatigue and increase wakefulness. The
benefit of caffeine consumption on athletic performance in large doses (3-9 mg/kg
body weight or BW) is frequently documented in aerobic athletes. The benefits of
caffeine supplementation in resistance training variables, such as muscular endurance,
has shown mixed results, partially due to the inconsistency of testing variables.
Furthermore, while caffeine supplementation shows promising ergogenic effects in
muscular endurance in elite athletes, it is unknown if this effect translates to the
recreational athlete. Therefore, the purpose of this study is to observe the potential
ergogenic effect caffeine supplementation may have in recreational athletes and to
consider how caffeine habituation may influence individuals’ response to a high
dosage of 7 mg/kg BW.
Design: This study used a randomized, double-blind crossover design. Subjects
performed bench press and Smith machine squat repetitions to failure using 60% of
their respective one repetition maximum (1RM), vertical jump, and isometric squat
tests. Subjects consumed either caffeine equivalent to 7 mg/kg BW or placebo 60
minutes prior to testing. Test sessions were separated by 7 days. Number of complete
bench press and Smith machine squat repetitions, vertical jump height, and isometric
power were evaluated. Rating of perceived exertion (RPE) was also recorded and
assessed. A repeated measures analysis of variance (ANOVA) was used to determine
differences between treatments.

Subjects: Subjects were healthy college age males with at least 6 months of prior
strength training experience (n=23, 22.0±2.2 years).
Results: There was no effect of treatment order. There was a significant increase in
bench press repetitions to failure between caffeine (18.9±3.7) and placebo (17.3±3.7,
p=0.002). There was a significant increase in Smith machine squat repetitions to
failure between caffeine (17.2±4.7) and placebo (15.3±4.5, p=0.018). No significant
difference was found in vertical jump or isometric force plate tests between
treatments. RPE was not statistically different between treatments.
Conclusions: This study suggests that acute caffeine supplementation equivalent to 7
mg/kg BW has an ergogenic effect in recreationally trained males in resistance
training exercises. RPE was not statistically different between treatments, indicating
that caffeine supplementation may also reduce perception of exertion relative to the
amount of work performed immediately following a bout of high-intensity resistance
exercise to failure.
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PREFACE
This thesis was written to comply with the University of Rhode Island Graduate
School Manuscript Thesis Format. This thesis contains one manuscript entitled “The
Effect of Caffeine Supplementation on Muscular Endurance in Recreationally Active
College Age Males”. This manuscript has been written in a form suitable for
publication in The Journal of Strength and Conditioning Research.
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ABSTRACT
Caffeine is a substance consumed regularly by approximately 90% of adults
worldwide, primarily due to its ability to reduce fatigue and increase wakefulness. The
benefit of caffeine consumption on athletic performance in moderate doses (3-9 mg/kg
body weight or BW) is frequently documented in cardio-respiratory endurance
athletes. The benefits of caffeine supplementation in resistance training variables, such
as muscular endurance, have shown mixed results, partially due to the inconsistency of
testing variables. Whether recreational athletes experience ergogenic results in
resistance activity from caffeine supplementation is currently unknown. This study
evaluated caffeine’s potential effects at 7 mg/kg BW on resistance training variables in
recreational athletes.
Male subjects (n=23, 22.1±2.2 years) were recruited for this randomized, double-blind
crossover trial. Subjects performed bench press and Smith machine squat repetitions to
failure using 60% 1RM, vertical jump, and isometric squat tests. Subjects consumed
either caffeine equivalent to 7 mg/kg BW or placebo 60 minutes prior to testing.
Number of complete bench press and Smith machine squat repetitions, vertical jump
height, isometric power, and rating of perceived exertion (RPE) were assessed.
Repeated measures ANOVA was used to determine differences between treatments.
Significance was set at p≤0.05. There was no effect of treatment order. There was a
significant increase in bench press repetitions (p=0.002) and Smith machine squat
(p=0.018). This study suggests that acute caffeine supplementation equivalent to 7
mg/kg BW has an ergogenic effect in recreationally trained males in these two
resistance training exercises.

3

Key words: resistance exercise, repetitions to failure, ergogenic aid
INTRODUCTION
Caffeine, a drug sought for its ability to increase wakefulness and reduce
fatigue, is one of the most widely consumed drugs in the world (29). Caffeine is found
in products such as coffee and tea, soda and energy drinks, ice cream, chocolate, and
nutrition supplements. Evidence suggests caffeine consumption may have an
ergogenic effect in a wide variety of athletic performance, including cardiorespiratory
endurance events and high-intensity, short-duration activities (2, 13, 14, 22, 27). While
the effects of caffeine on aerobic performance have been investigated extensively in
exercises such as running, cycling, and rowing, the effect of caffeine in resistance
training variables such as muscular endurance are inconclusive (5, 13).
A common method of measuring muscular endurance in caffeine trials is by
having subjects perform repetitions to failure using a percentage of their maximum
lifting ability, or 1-repetition maximum (1RM) (10). A study by Woolf, et al. (34)
found no significance between treatments in bench press to fatigue in caffeine-naïve
collegiate football athletes using 5 mg/kg, while Duncan, et al. (11) found significance
in bench press repetitions to failure using the same dosage in University-level rugby,
football, and basketball players. A study by Astorino, et al. (2) found no differences
between treatments in resistance-trained men who ingested caffeine equivalent to 6
mg/kg. While a limited amount of literature exists evaluating lower doses of caffeine,
the consensus suggests there is not an ergogenic effect in muscular endurance at 5-6
mg/kg body weight (BW) (2, 10).
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The majority of existing research focuses on subjects of elite athletic status,
often with several years of experience in resistance training exercise. Less research has
been performed on the impact of acute caffeine ingestion on strength and endurance in
the average individual who participates in light to moderate consistent physical
activity. Therefore, in our study, we had recreationally trained athletes perform a
combination of resistance exercises incorporating large muscle groups in both upper
and lower body while ingesting a dose of caffeine equivalent to 7 mg/kg of body
weight. Our primary hypothesis is that acute caffeine ingestion in the amount of 7
mg/kg of body weight will increase the number of bench press repetitions to failure
compared to placebo ingestion in college age, recreational male athletes. Our
secondary hypotheses is that acute ingestion of caffeine will also increase the number
of squat repetitions to failure, increase the amount of force generated from a vertical
jump and isometric squat exercise, and decrease rating of perceived exertion (RPE) at
the time of testing, when compared to placebo ingestion.
Furthermore, previous studies have not taken body composition into
consideration for caffeine dosing (2, 13, 22). Considering caffeine metabolism does
not occur in adipose tissue (1), our exploratory hypothesis is that subjects with lower
body fat percentage will demonstrate a significant increase in repetitions to failure in
bench press and squat exercises when ingesting caffeine when compared to subjects
with a higher body fat percentage.
METHODS
Experimental Approach to the Problem
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This study employed a within-subjects, repeated-measures design. Through
informed consent, subjects were notified they were participating in a research study
examining the effect of caffeine as an ergogenic aid on resistance exercise
performance. Subjects were made aware they would be asked to perform a 1RM test
on the bench press and Smith machine squat, and on two subsequent testing sessions
they would be required to perform bench press and Smith machine squat exercises to
failure at an intensity of 60% 1RM following ingestion of capsules containing either
caffeine equivalent to 7 mg/kg BW or a placebo. Subjects were told they would not be
informed which order they would receive each treatment, and that the researchers
performing the study were also unaware. Since prior research has demonstrated that
acute caffeine ingestion may impact a range of physiological and performance
variables, the experimental design (caffeine vs. placebo ingestion) was used to
examine the effect of the independent variable on the following dependent variables
that previous authors have suggested are influenced by caffeine ingestion: bench press
repetitions to failure, Smith machine squat repetitions to failure, vertical jump height,
isometric force, and RPE. All testing took place within the institution’s health fitness
laboratory.
Subjects
After approval from the university’s Institutional Review Board and collection
of subjects’ individually signed informed consents, 24 males (22.1±2.2 years)
completed the testing protocol. As inclusion criteria, all subjects were free from any
musculoskeletal pain or disorders, and reported a minimum of 6 months of consistent
resistance training for at least two days a week. Subjects with a weight greater than
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225 lbs. (102 kg) were not enrolled in the study in order to prevent dosages exceeding
double the daily amount generally recognized as safe (400 mg) (19). Additional
exclusion criteria included smoking, medical history significant for hypertension,
diabetes, renal insufficiency, cardiac abnormality, or other chronic disease. Subjects
were asked to refrain from vigorous exercise 48 hours before testing. In addition,
subjects were provided a list of caffeine-containing products and were asked to abstain
from caffeine-containing products beginning at 6:00pm the evening before each
testing session. This was verified via a modified caffeine consumption questionnaire
completed for the 24-hour period before each session, as well as a 24-hour food recall.
Of the 24 subjects recruited, 1 subject was removed for not adhering to the pre-testing
protocol.
Procedures
Subjects attended the Health Fitness Laboratory (HFL) during each visit, all on
an individual basis. The first visit also included collection of anthropometric data in
the Body Composition Laboratory (BCL), where height, weight, and body fat
percentage were collected. Height in centimeters was measured using a Seca 216
stadiometer (Seca, Hanover, MD) to the nearest tenth of a centimeter. Weight was
measured in kilograms with a Tanita scale (Tanita Corporation, Japan) to the nearest
tenth of a kilogram. Height and weight were measured using standard procedures (24),
and body mass index (BMI) was calculated as kg/m2. Body composition was assessed
by air displacement plethysmography using a Bod Pod and its respective software
(Cosmed, Concord, CA). Standard procedures, including Bod Pod calibration prior to
data collection, were followed (31). Total body estimates of percent fat were
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computed from the measured body volume using the Siri equation (28). During the
initial visit, 1RM strength testing for the bench press and squat exercises was
conducted using National Strength and Conditioning Association (NSCA) guidelines
in the HFL (3). In addition, subjects completed a health history questionnaire and
caffeine frequency questionnaire for screening and descriptive purposes, during the
initial visit.
Muscular Strength
During the pre-test visit, subjects were asked to estimate their 1RM for the
bench press and Smith machine squat. For each exercise, fifty percent of their stated
1RM was calculated, and subjects were asked to perform 5-10 complete repetitions.
After 3 minutes of rest, subjects were asked to perform 3-5 complete repetitions based
on 70% of their stated 1RM. Subjects then would perform 1-2 repetitions of gradually
increasing weights, with three minute rests in between, until they were no longer able
to complete a full repetition. This was performed to estimate the maximum amount of
weight the subject can lift one time and served as the value for calculating the amount
of weight to be used during testing visits (9).
Muscular Force and Calculated Vertical Jump Height
Muscular power was assessed by an isometric squat and vertical jump exercise.
Force and power were measured using a force plate and Accupower software (AMTI,
Watertown, MA). Following subject familiarization of the isometric squat protocol,
subjects were asked to stand on the force plate in a quarter-squat position under a
Smith machine squat bar. Once in position, subjects were asked to push against the
stationary bar maximally for 10 seconds. Knee angle was measured with a goniometer.
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Angle of the knee can be within a range of 100-135 degrees; this number was the same
for both test trials (18).
Subjects were also familiarized with the vertical jump protocol and asked to
perform three consecutive, maximal effort jumps. Procedure for the vertical jump
required subjects to have hands placed on their hips and feet shoulder-length apart
during the exercise. Subjects performed this exercises an additional two times, with 23 minutes of rest between each set. The highest force, power, and jump height in the
three sets were recorded and averaged.
Muscular Endurance
Muscular endurance for both the bench press and Smith machine squat were
assessed using 60% of the subjects’ measured 1RM. Following familiarization of the
exercise protocol, subjects were asked to perform a single set of repetitions of each
exercise until failure. A trained tester was used to count the number of repetitions
completed and to ensure each repetition was completed with proper form. A second
trained tester was present to assist with counting complete repetitions performed.
Rating of Perceived Exertion
RPE was assessed before and after each exercise using the Borg CR-10 scale
(8). Prior to the start of exercises, instructions on how to use the Borg CR-10 scale
were read to each subject. The scale is ranked from 0 (resting state) to 10 (maximal
effort) and assesses how strenuously the subject perceived he worked, based on the
self-reported number chosen.
Caffeine and Placebo Administration
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Subjects were supplied caffeine in the form of encapsulated powder. Seven
mg/kg BW were used to determine the total dose for each subject. Placebo capsules
were filled with microcrystalline cellulose free of the eight major allergens as well as
gluten. Caffeine or placebo was ingested one hour prior to experimental trials to
achieve maximum plasma concentration (16). Subjects were provided 12 fluid ounces
of water to aid in capsule ingestion. Once the subject had ingested caffeine or placebo
capsules, he remained stationary for 45 minutes, viewing TED Talks© or reading
magazines. At 45 minutes, subjects were tested for hydration status by using a
refractometer. Inadequate hydration was determined by a specific gravity of 1.024 or
greater (25). Subjects who were found to be inadequately hydrated were provided an
additional 12 fluid ounces of water to consume.
Statistical Analysis
G-power (G*Power, Version 3.1.9.2) was used to determine sample size using
results from a similar study analyzing bench press repetitions in collegiate athletes
ingesting 5 mg/kg body weight of caffeine versus placebo (12). An alpha level of 0.05,
with an effect size = 1 and power = 0.8; this revealed an adequate sample size of 23
subjects. Data were analyzed using SPSS (version 23; SPSS, Inc. Chicago, IL). A
repeated measures analysis of variance (ANOVA) was used to analyze the primary
and secondary hypotheses. Assumptions for normality were tested and met for all
variables using skewness and kurtosis. Pearson correlations were run to examine
exploratory hypotheses. For RPE, a 2x2 repeated measures ANOVA was run to
compare pre and post RPE values with both the caffeine and placebo treatment.
Significance for all analyses were set at p≤0.05.
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RESULTS
Subject demographics are presented in Table 1. Mean BMI was 25.5±3.0
kg/m2. Body fat percentage was 15.8±16.4. Mean 1RM was 92.2±22.8 kg in the bench
press and 114.7±22.9 kg in the squat test.
Results indicated that subjects completed significantly more repetitions to
failure with the caffeine treatment compared to placebo in both the bench press (mean
difference of 1.4 repetitions, p=0.006) and Smith machine squat (mean difference of
1.5 repetitions, p=0.032) (Figure 1). Treatment order was not significant in either test.
There were no significant differences in average vertical jump height (Figure 2) or
isometric force (Figure 3) between treatments.
With respect to lean body mass, no correlations were found with performance
in the caffeinated condition in the bench press or Smith machine squat tests. No
correlations were found in bench press or Smith machine squat tests with self-reported
caffeine habituation under the caffeinated condition. Data not shown.
Rating of perceived exertion was not significantly influenced by condition
bench press or squat tests, as determined by 2 (time) x 2 (treatment) repeated measures
ANOVA. Rating of perceived exertion was significant in the isometric squat test
between treatment and time; however, significance was lost when controlling for
treatment order.
DISCUSSION
Both the bench press and Smith machine squat tests resulted in a significant
increase in number of repetitions when subjects received the caffeine treatment
compared to placebo (Figure 1). These results are consistent with previous studies
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performed in individuals with a greater training status (2, 11). Astorino et al. (2)
observed 19.9±4.3 repetitions in the caffeine condition versus 18.4±4.0 with placebo
in a study evaluating 22 resistance-trained males with a training history of 6.0±2.8
years. This mean difference of 1.5 repetitions in the bench press is nearly identical to
that observed in the present study (1.4 repetitions) (2). Duncan et al. (11) observed an
average of 22.4±3.0 repetitions in the caffeine condition and 20.4±3.4 with placebo,
resulting in an increase of 2 repetitions - 0.6 repetitions greater than observed in the
present study. In that study, all subjects were highly experienced in the respective
sport (rugby, basketball, football) at the University level and have been competing in
their sport for a mean time of 10.4±2.3 years (11). Therefore, the present study
suggests that caffeine supplementation in recreational athletes has similar ergogenic
effects to that which has been observed in athletes trained in their respective sports for
longer durations.
This study examined the acute effect of a high dose of caffeine on muscular
endurance and sought to address gaps in the literature by employing a design where
multiple resistance exercises were utilized and a population of recreationally trained
athletes was analyzed. Employing the bench press, Smith machine squat, and
isometric force plate arguably create a greater level of fatigue than studies examining
performance in a single exercise. The bench press test in particular is an exercise
frequently used in studies evaluating the impact of caffeine in muscular endurance;
employing this test in our study allows us to compare efficacy in our population with
groups that have been previously evaluated (2, 5, 32). The present study also sought to
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recruit subjects who participate in resistance training activity on a recreational basis,
which was defined as a minimum of twice a week for a period of at least six months.
Other researchers have suggested that caffeine may have different effects for
upper- versus lower-body exercise (5, 10). Davis et al reported that the ergogenic
effect of caffeine may not elicit effects for leg musculature until later into an exercise,
when fatigue plays a more prominent role, compared to earlier sets of repetitions (10).
In contrast, tests using upper-body musculature have shown greater improvements in
earlier sets, such as a study by Beck et al which found significant increases in bench
press repetitions to failure, but not in bilateral leg extension (5).
The increases in both upper and lower endurance exercises observed in the
present study are not consistent with previous literature, and may be explained due to
the population recruited. Previous literature has questioned whether the ergogenic
properties of caffeine are limited by the amount of muscle mass recruited and the total
number of repetitions performed (10). This question is plausible given the absorptive
properties of caffeine: when absorbed, caffeine is able to distribute freely into
intracellular tissue water, allowing the transport to metabolic tissue such as the muscle
and brain (1). Therefore, our exploratory hypothesis sought to determine whether
subjects with a lower body fat percentage (and thus a higher percentage of
metabolically active tissue) would benefit from the ergogenic effects of caffeine than
those with a higher body fat percentage. To the researchers’ knowledge, this is the first
study examining the dosage each subject received based on lean body mass. The range
of body fat percentages recorded was 5.8-27.1%, and the caffeine dosage averaged 8-9
mg per kg lean tissue. Despite this, there were no significant correlations between
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calculated body fat percentage and performance in any of the four tests when subjects
received the caffeine treatment. This suggests that the ergogenic effect of caffeine was
not greater in individuals with a lower body fat percentage.
Additionally, there was no correlation in performance in the bench press or
Smith machine squat tests with caffeine habituation. An early review article by
Graham concluded that any differences caused by caffeine habituation do not appear
to be significant (16). Moreover, a study by Astorino et al. evaluated the efficacy of 6
mg/kg BW caffeine versus placebo on bench press, leg press, lat row, and shoulder
press; results found that 66% of subjects who demonstrated increases in the caffeine
condition were relatively heavy caffeine users, while subjects who had reduced
performance in the caffeine condition consumed less than 150 mg/day (2). Of note, the
study had a sample size of 14 men with resistance training experiences >2 days/week
for 7.5+1.2 years, who all identified as daily caffeine consumers; as a result, it cannot
be concluded that caffeine habituation has a significant impact on resistance training
variables (2).
Bloms et al. reported significantly higher vertical jump performance in
Division I collegiate athletes who consumed 5 mg/kg BW of caffeine (7). They
concluded the ergogenic of caffeine in vertical jump performance is likely to only be
observed in subjects who are frequently exposed to repeated ballistic tasks, such as
basketball and volleyball players (7). The current study did not recruit individuals
based on experience in sports or other activities that may predispose individuals to
activities requiring frequent jumping (Figure 2). Furthermore, subjects were not
familiarized with the vertical jump protocol prior to the test visits. To our knowledge,
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there has not been a caffeine trial in vertical jump exercises in recreationally active
athletes naïve to ballistic activity. Therefore, is it plausible that the proposed
conclusion by Bloms et al. may explain the results witnessed in the present study,
which found no significant difference in calculated vertical jump height (7).
Previous literature has hypothesized that caffeine does not alter maximal forcegenerating capacity of a muscle, but may extend time to fatigue by altering pain
perception (10). This would explain the results observed from the isometric force test,
which had no significance between the caffeine treatment and placebo (Figure 3). To
the researchers’ knowledge, this may be the first study to use the isometric force test
in order to measure maximal isometric force generation in recreational athletes.
Results from the present study support the hypothesis that caffeine does not
significantly alter maximal force-generating capacity.
While there are several mechanisms that may play a role in the observed
ergogenic effects of caffeine, the most prominent mechanism of action involves
caffeine’s ability to inhibit adenosine receptors (20). Adenosine, a molecule similar in
structure to caffeine has been shown to enhance pain perception, induce sleep, and
reduce arousal, among other functions (6, 23, 30). Caffeine, which has a nonselective
affinity to adenosine receptors, can bind to adenosine receptors in the brain and
peripheral tissues (15). The resulting inability of adenosine to bind to receptor sites
prevents the adenosine-induced suppression of dopamine release (10). This contributes
to the reported increase in arousal and alertness frequently associated with caffeine
intake (26). As a result, it is believed that the primary mechanism of action is
inhibitory effects on adenosine modifying pain perception while sustaining motor unit
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firing rates, resulting in an overall ergogenic effect (10). The resulting inhibition of
adenosine in the presence of caffeine may justify why a significant improvement was
found in the two tests that utilized muscular endurance, but not in the tests that
evaluated a short-duration (<10 second) bout of force, such as the isometric force test,
or the vertical jump test, which arguably did not drastically increase subjects’
perceived exertion (7, 10).
Rating of perceived exertion was not significantly different in the bench press
or Smith machine squat test between treatments. These results are consistent with a
range of studies that have also found no difference in RPE with resistance exercise (4,
11, 17, 33). A proposed reason for the lack of a dampening effect on RPE following
caffeine ingestion is the short duration in exercise to failure in a given exercise (such
as bench press or squats) is insufficient to elicit a perceived difference in exertion
between treatments (11). Evaluating caffeine supplementation at later time points
following resistance training exercise has shown decreased perception of exertion in
caffeine treatments. For example, Hurley et al (21) found decreased perception of
exertion following bench press exercises at 72 hours post-exercise.
Despite the non-significant findings in this current study, subjects had
improved performance in the bench press and squat tests without having a significant
change in RPE between treatments. This is in opposition of the results of a study by
Duncan et al, where subjects had no significant difference in number of bench press
repetitions between 5 mg/kg caffeine and placebo, but did have a lower RPE in the
caffeine condition (13). As a result, it can be argued that RPE was not reduced as a
result of the caffeine treatment in the present study, but perception of exertion was
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maintained in the caffeine treatment while subjects completed an additional 1.4
repetitions, on average.
There were several limitations to this study. This study sought out to evaluate a
population of recreationally trained athletes. While all subjects recruited met the
minimum requirements, there was large variability in training experience among
subjects, ranging from the minimum requirements to amateur power lifter. Number of
years of resistance training experience was not documented. Subjects were primarily
Caucasion; future research should recruit a more diverse population to increase
generalizability. Additionally, some subjects noted discomfort when using the Smith
machine – particularly when performing the ISO test, which required subjects to exert
themselves onto a bar anchored in place. For this reason, subjects may have
unconsciously chose to exert themselves less on the second visit compared to the first.
However, to control for potential order effects, the order that subjects received each
treatment was randomized; no significant differences were found in perceived exertion
between the first and second visit. Also, there were two investigators who conducted
the subjects’ test sessions. However, both testers were trained by the same researcher.
Furthermore, analysis determined there was no significant difference in any of the four
tests when controlled for investigator.
In contrast to the limitations, there were many strengths to the study. First, the
study was a double-blind, cross-over design. Also, each subject acted as his own
control. This randomization of treatment order limits the chance of improvement due
to test familiarization. Finally, several steps were taken to ensure that all measures
were taken in an identical manner. Hydration status was tested to ensure subjects were
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adequately hydrated prior to testing by determining urine specific gravity. Subjects
met at the same time of day for each visit. Subjects abstained from physical activity
for 48 hours prior to test days and caffeine-containing products from 6:00pm the
evening before testing. Additionally, subjects were instructed to consume the same
meal on each test day; this was confirmed by performing a 24-hour food recall prior to
testing. Finally, this study evaluated recreational athletes, a population that makes up a
greater percentage of the population when compared to elite athletes. For this reason,
the results of this study are applicable to a larger population.

PRACTICAL APPLICATIONS
The effectiveness of caffeine supplementation to improve performance in
resistance training exercise in recreational athletes remains somewhat unclear. The
results of this investigation demonstrate that caffeine increases number of repetitions
in muscular endurance exercises that employ large upper and lower muscle groups
such as the bench press and Smith machine squat. Caffeine habituation status does not
appear to have an impact on the potential ergogenic effects of caffeine. While the
average increase in repetitions was considerably low (1.4 repetitions in the bench press
and 1.5 repetitions in squats), the increases in repetitions over time may be favorable
in the population observed, due to a chronic training effect. While one set of
repetitions to failure was employed for this test, future research should evaluate the
same population using multiple sets of repetitions, as caffeine supplementation may
increase muscular endurance while maintaining RPE as demonstrated in the present
study. However, despite the observed increases in muscular endurance measures, a
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high dose of caffeine was required to achieve the observed results. The practical use of
such a dosage (7 mg/kg BW) in a free-living environment is questionable. As with any
supplement study, there will be subjects who respond to treatment and those who not
only do not respond, but also experience an undesirable effect. For this reason, health
professionals and educators should consider recommending caffeine trials to clients on
an individual basis to determine if supplementation will yield desired results.
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FIGURES
Figure 1: Number of Bench Press and Squat Repetitions by Treatment
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BP=Bench press, S=Squat. (n=23) Data analyzed using repeated measures ANOVA. There was a
significant increase in repetitions to failure between caffeine and placebo treatments in both the bench
press and squat tests. *p<0.05, **p<0.01.
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Figure 2: Calculated Vertical Jump Height in cm by Treatment
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(n=23) Average calculated vertical jump height in cm by treatment. Subjects performed three sets of
three jumps, with the highest average jump height recorded. Data analyzed using repeated measures
ANOVA. No significance found between caffeine and placebo treatment.
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Figure 3: Force Generated During Isometric Force Test by Treatment
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(n=23) Force generated in isometric force plate test by treatment. Data analyzed using repeated
measures ANOVA. No difference between caffeine and placebo treatment.
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TABLES
Table 1. Subject Characteristics
Characteristics of subjects (n=23). 1RM Squat = 1 repetition maximum in squat
exercise, 1RM Bench Press = 1 repetition maximum in bench press exercise.
Anthropometrics are presented as mean ± SD.
Gender
Male

23 (100%)

Ethnicity
African-American
Asian-American
Caucasian
Hispanic/Latino

2 (8.7%)
1 (4.3%)
18 (78.3%)
2 (8.7%)

Height (cm)
Weight (kg)
BMI (kg/m2)
Body fat (%)
Age (years)
1RM Squat (kg)
1RM Bench press (kg)

176.4 ± 6.4
79.5 ± 9.9
25.5 ± 3.1
15.8 ± 6.6
22.1 ± 2.2
115.8 ± 22.7
93.1 ± 22.8

Self-Reported Caffeine Intakea
Abstain
Low
Moderate
High

4 (17.4%)
11 (47.8%)
4 (17.4%)
4 (17.4%)

a

Self-reported caffeine intake is defined as: abstain: ≤ 8 oz. caffeine-containing products per week; low:
≤ 8 oz. caffeine-containing products per day; moderate: 8-16 oz. caffeine-containing product per day;
high: >16 oz. per day.
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Appendix I: Review of the Literature
Overview
This literature review will discuss different types of resistance training
variables – specifically, muscular strength and muscular endurance – and provide a
synopsis of the previous literature on cardio-respiratory endurance and resistance
training trials utilizing caffeine as an ergogenic aid. First, we will define strength and
endurance and provide methods of measuring muscular strength, muscular endurance,
and vertical jump height. Then, we will discuss the availability of caffeine in the diet
along with its absorption, metabolism, and several potential mechanisms that may
explain its ergogenic effects in athletic exercises. Finally, we will provide an overview
of the previous literature describing caffeine as an ergogenic aid in both cardiorespiratory endurance and resistance training.
Resistance Training Variables
Muscular Strength
Muscular strength is defined as the maximum force or torque produced by a
muscle group in an isometric action at a specific joint angle (42). The 1-repetition
maximum (1RM) is currently the gold standard for determining isotonic strength (15).
The American Society of Exercise Physiologists recommend performing 1RM squat
and 1RM bench press tests to assess lower body and upper body strength, respectively
(15). However, 1RM testing is perceived as a potentially dangerous test to perform;
for that reason, methods that employ using a submaximal weight (<1RM) to estimate
1RM in athletes are often used (15). Repetitions with a submaximal weight (<1RM)
are used to accurately estimate 1RM performance in strength endurance exercises,
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such as the bench press (49). Estimated 1RM can be accurately calculated by
employing up to 10 repetitions using submaximal weight, such as in a 5RM or 10RM
test (65).
Previous studies have shown that lighter loads, such as 40 and 60% 1RM,
lifted to exhaustion can accurately predict 1RM bench press strength (5, 38). However,
absolute load tests are alternative methods to predicting 1RM by utilizing a constant
weight; these methods have also been found to be accurate predictors of 1RM in
college-age men (38). The most common absolute load test, utilized by the National
Football League as well as at the college and high school level, employs performing
the maximum number of repetitions possible using constant weight of 225 pounds
(50). Results from this test, known as the NFL-225 Test, has been shown to accurately
calculate 1RM; however, the absolute load test is only able to be used in subjects
whose 1RM bench press is greater than 225 pounds (15, 50). In research such as the
present study where subjects recruited have a wide range of strength training
experience, this method of calculating 1RM is not suitable. For this reason, we utilized
each subject’s own submaximal weight as a method to calculate 1RM. This way, the
amount of weight used for each subject was relative to his individual resistance
training ability.
Muscular Endurance
In most laboratory studies, endurance performance is measured as the time
taken to reach exhaustion at a given power output (70). Resistance training programs
that emphasize muscular endurance typically involve many repetitions – typically 12
or more – per set (4). Despite this high number of repetitions, loads lifted are lighter
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than in exercises evaluating muscular strength, and fewer repetitions (usually 2-3) are
performed (4). This is in contrast to strength training exercises, where loads used are
typically higher and the number of repetitions are lower (6 or less) (4). A common
method of measuring muscular endurance performance is by using repetitions to
failure (17). Repetitions to failure involve performing sub-maximal force production
in several repetitions until fatigue, and is usually performed with a percentage of 1RM
(17).
Table 1: Volume Assignments Based on Training Load (4)
Training goal

Goal repetitions

Sets*

Strength

≤6

2-6

**Power
Single-effort event
Multiple-effort event

1-2
3-5

3-5
3-5

Hypertrophy

6-12

3-6

Muscular endurance

≥12

2-3

*These assignments do not include warm-up sets and typically apply to core exercises only.
**The repetition assignments shown for power in this table are not consistent with the %1RMrepetition relationship. On average, loads equaling about 80% of the 1RM apply to the two- to fiverepetition range.

Vertical Jump Height
The vertical jump (VJ) test is the primary test used to asses muscular power in
the legs (15). There are two forms of the VJ test utilized: the squat jump (SJ) and the
counter-movement jump (CMJ) (15). Both the SJ and CMJ can be performed with or
without the use of arm motions (15). When arm motions are not allowed, subjects are
required to place hands on their hips (15). While the CMJ generally results in higher
jump heights than the SJ, Sayers, et al has argued that SJ is a preferred testing method
due to the variability in CMJ technique as well as the accuracy in calculating peak
power (68).
29

Caffeine
Intake & Metabolism
Caffeine (1,3,7-trimethylxanthine), found in coffee, tea, soft drinks, and dietary
supplements, is the most used pharmacologically active substance in the world, with
the average American adult consuming 2.4 mg/kg/day (76). Consumption of up to 400
mg (equivalent to 4 mg/kg body weight in a 90 kg person) of caffeine per day has been
determined to be a safe level in adults (35). The average US adult’s coffee
consumption is about two cups per day (about 280 mg of caffeine). In addition,
hundreds of caffeinated beverages exist, ranging from 50 to 500 mg per can or bottle
(equivalent to 0.5-5.5 mg/kg body weight in a 90 kg person) (64).
Caffeine can be absorbed via oral, rectal, or parenteral route, and maximum
blood concentration of caffeine in humans is achieved in one hour after absorption
through the gastrointestinal tract (63). Peak absorption has been determined to be
around 30 minutes in popular products such as colas and coffees, and around 60
minutes in encapsulated forms (44). The half-life of caffeine has a range of 2-12
hours; however, plasma concentration is dependent on time since previous
consumption and other dietary factors, such as fiber (a structural polysaccharide that
resists chemical breakdown by digestive enzymes (1, 29, 33, 51).
Caffeine binds to plasma proteins and is able to distribute freely into
intracellular tissue water, accounting for 10-30 percent of the total plasma pool;
caffeine is also lipophilic and is able to cross the blood-brain barrier (1, 71).
Metabolism of caffeine occurs in the liver through processes of demethylation and
oxidation (33). The primary route of caffeine metabolism is 3-ethyl demethylation to
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paraxanthine; this step makes up approximately 75-80 percent of caffeine metabolism
and involves cytochrome P4501A2 (1). Caffeine is also metabolized to theophylline
and theobromine, however metabolism to paraxanthine is the primary metabolic
pathway (1). Caffeine is also reabsorbed by the renal tubules, however only a small
amount of caffeine is excreted in urine unchanged (1). Repeated ingestion of caffeine
does not alter absorption or metabolism of caffeine (28). Research does suggest
menstrual cycles or use of oral contraceptives may alter caffeine clearance (43).
Physiology
Caffeine is both water and fat soluble, which allows distribution to all tissues
of the body (1, 2, 54, 71, 73). As a result, a specific mechanism of action in regards to
exercise performance has yet to be chosen (73). There are several principle
mechanisms that have been proposed to explain the ergogenic potential of caffeine
during exercise: 1) increased myofilament affinity for calcium and/or the increased
release of calcium from the sarcoplasmic reticulum (SR) in skeletal muscle; 2) cellular
action caused by the accumulation of cyclic-3’-5’-adenosine monophosphate (cAMP)
in tissues such as skeletal muscle and adipocytes; 3) cellular actions mediated by the
competitive inhibition of adenosine receptors in somatic cells and the central nervous
system (19). Additionally, early research by Powers et al. suggest that the ergogenic
effects of caffeine in aerobic exercise is related to an increase in fatty acid oxidation,
leading to the sparing of muscle glycogen (62). Increased oxidation of fatty acids
inhibits glycogen phosphorylase activity, switching the preference from glycogen to
fat (60, 67). This resulting increase in free fatty acids is hypothesized to decrease
cellular lactic acid production, a pathway that has been linked to fatigue during heavy
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exercise (62). Recent research, however, has found little evidence to support the
hypothesis that caffeine has ergogenic effects due to enhanced fat oxidation (31).
Graham, et al conclude individuals may respond differently to the effects of caffeine,
which could be explained by genetic variations (31). Further potential mechanisms are
described below.
Caffeine may reduce the excretion of calcium (Ca2+) that occurs during
exercise (30). Tallis, et al performed a review of numerous isolated muscle studies
examining the direct effects of caffeine (73). Results showed a greater release of Ca2+
into the intramuscular space, increased myofibrillar Ca2+ sensitivity, slowing of the
sarcoplasmic reticulum Ca2+ pump and increased SR Ca2+ permeability (73). This
combination of events significantly modified the performance of skeletal muscle, most
notably by increasing muscle relaxation time (73). However, Tallis et al concluded
that caffeine’s ability to cause significant improvements in muscle contractility is
likely a result of a number of synergistic effects, and less likely a single mechanistic
action (73).
Another proposed role of the ergogenic effect of caffeine involves calcium and
phosphodiesterase inhibition (17). In vitro studies have shown that caffeine inhibits
phosphodiesterase enzymes, allowing an increase in cAMP (17, 25). An increase in
cAMP, along with an increase in blood catecholamines (such as epinephrine), results
in the activation of hormone sensitive lipase (34). The resulting free fatty acids are
mobilized from the cell membrane of the adipocyte and are transported to tissues and
are oxidized for energy (34). However, this mechanism is unlikely to explain the
ergogenic effect of caffeine observed during athletic activity; while in vitro studies

32

have demonstrated inhibitory effects on phosphodiesterase, in vivo studies would
require toxic doses of caffeine to observe a physiological benefit (17).
Arguably the most favored mechanism of action involves caffeine’s ability to
inhibit adenosine receptors (36). Adenosine, a molecule similar in structure to caffeine
has been shown to enhance pain perception, induce sleep, and reduce arousal, among
other functions (12, 41, 72). Caffeine, which has a nonselective affinity to adenosine
receptors, can bind to adenosine receptors in the brain and peripheral tissues (26). The
resulting inability of adenosine to bind to receptor sites prevents the adenosineinduced suppression of dopamine release (17). This contributes to the reported
increase in arousal and alertness frequently associated with caffeine intake (55). As a
result, it is believed that the main mechanism of action is inhibitory effects on
adenosine modifying pain perception while sustaining motor unit firing rates, resulting
in an ergogenic effect (17).
Caffeine ingestion before exercise may cause the undesired effect of an
increase in the inflammatory response, demonstrated by increases in markers of
muscle damage and leukocyte cells (6, 75). As a result, an additional mechanism that
may aid in the ergogenic effect of caffeine involves creatine kinase (CK), a
physiological marker that indicates muscle damage and is associated with higher
levels of pain perception after acute episodes of resistance exercise (48). Creatine
kinase de-phophorylates creatine phosphate to enable rapid phosphorylation of ADP to
ATP for quick, intense muscle contractions (24). Previous literature suggests
resistance exercise results in an increase in CK concentrations (37, 48). Additionally,
other researchers have found that caffeine causes an increase in circulating
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catecholamines, such as epinephrine and norepinephrine, which are responsible for the
increase in leukocytes frequently observed post-exercise (11). Bassini-Cameron et al.
hypothesized the fatigue delaying effect of caffeine may even enhance the extent of
muscle damage occurring during intense exercise, as subjects can potentially perform
a higher volume of work following acute caffeine ingestion (6). However, this does
not explain the potential ergogenic effect during exercise, but instead addresses
muscle injury, and related muscle soreness, post-exercise. A study employing caffeine
equivalent to 4.5 mg/kg BW found that an acute ingestion prior to resistance exercise
does not appear to cause greater muscle cell injury, as CK and leukocytes observed
were not above levels that occurred in resistance exercise alone (48). Furthermore,
peak blood levels of CK and associated muscle soreness do not occur until 24 and 48
hours post-exercise (56). Recent literature shows caffeine ingestion before resistance
training may result in lower levels of soreness 2 and 3 days post-exercise (37). This
suggests that the potential negative effect caffeine may have on increasing CK and
leukocyte concentrations during exercise may be outweighed by both the ergogenic
effect frequently observed during exercise as well as the reduced muscle soreness
observed within the following days post-exercise.
Additional Effects of Caffeine
Caffeine has been noted to have multiple effects in the body. Caffeine acutely
raises blood pressure as a result of sympathetic system stimulation and the
antagonistic effect on adenosine (26, 69). These effects on the cardiovascular system
generally return to baseline after 10-60 hours, depending on the amount of caffeine
ingested (33). Both mood and cognitive ability improve following both acute and
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chronic caffeine consumption (26). Furthermore, caffeine has been shown to increase
alertness and ability to concentrate, and has long been used to treat headaches due to
its synergistic effects with analgesics; as a result, caffeine is an ingredient used both
alone or in conjunction with other medications, such as acetaminophen (9, 26, 47, 69).
Persons who abstain from caffeine overnight (8-12 hours) have a significant depletion
of caffeine by early morning; as a result, subjects are more sensitive to the stimulant
effects upon reintroduction into the body (66).
Caffeine’s impact on athletic performance has been investigated in a range of
athletic exercises, including endurance events, team sports, and high-intensity, shortduration activities (3, 23, 24, 39, 57). Due to the observed effects of caffeine, the
World Anti-Doping Agency has caffeine placed on the 2015 monitoring program (79).
While there is no restriction set to the amount of caffeine to be consumed prior to an
athletic event, caffeine concentration is monitored for potential repetitive misuse (10,
40, 79). Previously, the International Olympic Committee (IOC) prohibited urinary
caffeine concentrations in excess of 12 mcg/mL (52). This currently unrestricted limit
of caffeine can allow athletes to consume amounts of caffeine associated with
ergogenic benefits prior to athletic events. In a meta-analysis of caffeine studies
examining various types of physical activity performance, the amount of caffeine
commonly shown to improve endurance is between 3 and 6 mg/kg of body mass,
consumed no more than 60 minutes before activity (27).
Considering the multiple proposed mechanisms of caffeine, the remaining
sections of the literature review will review the effects of caffeine in aerobic and
anaerobic athletic performance.
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Aerobic Performance
The effects of caffeine on aerobic performance have been investigated
extensively in aerobic exercises, particularly in running, cycling, and rowing. Several
meta-analysis report that caffeine has an ergogenic effect on aerobic performance (20,
27). Doherty, et al (20) reviewed 40 double-blind studies evaluating a combination of
cycling, running, and rowing exercises in subjects with mixed reported habitual
caffeine intakes; the consensus was that 3-10 mg/kg of caffeine is necessary to have a
positive impact on exercise performance. Compared to placebo, caffeine improved test
outcomes by 12.3% on average (20). Ganio, et al (27) presented lower findings, citing
a mean improvement of 4.4+5.0% in 21 cycling trials, 0.9+0.7% in 6 running trials,
and 1.1+0.3% in 4 rowing trials. Ganio, et al determined that quantities above 3 mg/kg
are needed for improvement and that athletes consume up to 6 mg/kg no more than 60
minutes before exercise (27).
Desbrow, et al (18) compared the ergogenic effects of two different dosages of
caffeine, 3 mg/kg and 6 mg/kg, to placebo in 16 well-trained male cyclists. In this
randomized, double-blind study, participants performed cycling ergometer time trials
after receiving either 3 or 6 mg/kg of caffeine or placebo (18). Both treatments had
significant enhancements in endurance cycling, with 4.2% enhancement in the low
dose (3 mg/kg) treatment and 2.9% in the high dose (6 mg/kg) treatment (18). The
authors concluded that greater levels of circulating caffeine from higher dosages do
not equate to better performance outcomes (18).
In a double-blind crossover study performed by Bruce, et al, eight competitive
male rowers completed three trials of a 2000-m rowing test, each one hour after
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consuming either 6 or 9 mg/kg BW of caffeine or placebo (16). Both 6 and 9 mg/kg
BW caffeine led to an improvement in 2000-m simulated rowing time trial
performance (16). The 6 mg/kg and 9 mg/kg caffeine treatments had similar
improvements in performance; however, one-third of the subjects had urinary caffeine
concentrations at or above 12 mcg/L when they received 9 mg/kg BW caffeine, which
exceeds the limit set by the IOC (10, 16). As a result, Bruce, et al recommends
utilizing trial doses of caffeine equivalent to ~6 mg/kg for competitive male athletes
(16).
In a double-blind, placebo-controlled trial performed by O’Rourke et al, 15
recreational and 15 well-trained runners (gender was undisclosed) completed two 5
kilometer time-trials following ingestion of either 5 mg/kg caffeine or placebo (58).
The caffeine treatment had significant improvements in performance in both
recreational and well-trained groups (1.0% and 1.1%, respectively) (58). However, the
authors questioned the practical significance of the results, citing a small beneficial
effect (58).
Paton, et al utilized a dose of 6 mg/kg caffeine or placebo in a randomized,
double-blind, crossover experiment with 16 male team-sport athletes (59). Subjects
performed 10 sets of 10-second sprints, with each sprint followed by 10 seconds of
rest (59). The observed effect of caffeine was not significant in sprint performance and
on fatigue; in fact, the caffeine treatment was found to have a slight decrease in agility
(59).
Despite the extent of which the effect of caffeine has in aerobic performance, a
specific recommendation on dosage has yet to be determined. Based on two meta-
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analyses, a wide range of dosage recommendations are proposed: Doherty, et al
propose an effective range of 3-10 mg/kg, while Ganio, et al offers an arguably
smaller range of 3-6 mg/kg (20, 27). In the research performed by Desbrow, et al, it
was concluded that higher doses of caffeine do not equate to better performance, while
Bruce, et al concluded that doses of 6 mg/kg and 9 mg/kg resulted in similar
performance, but the latter dose exceeded limits set by the IOC (16, 18). Despite the
variability in dosing amongst studies, the general consensus among meta-analyses is
that dosage of caffeine no more than 60 minutes prior to exercise may provide
ergogenic benefits, however dosage amounts are to be further investigated on an
individual level that accounts for multiple factors, such as subject habituation,
ingestion timing, and ingestion mode (capsule versus liquid, for example) (27). Ganio
et al. also recommend that subjects abstain from caffeine for 7 days before use to give
caffeine the greatest chance of optimizing the ergogenic effect (27).
Anaerobic Performance
Similarly to aerobic performance, the effects of caffeine supplementation in
anaerobic exercise have been reviewed at length. However, testing methods chosen in
anaerobic testing have been less consistent, partially because anaerobic performance
can be more difficult to quantify (30). A review of the literature indicates uncertainty
towards whether the perception of athletic improvement is related to maximum
strength, power, or rate of fatigue (30).
Conflicting results have been found in the literature regarding caffeine and
1RM. Beck et al examined 1RM for bench press and leg extension exercises in 37
resistance-trained males (7). A significant improvement was found in bench press
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1RM but not in the leg extension (7). However, Williams et al and Astorino et al both
failed to find and effect for 1RM in the bench press and leg press in 9 resistancetrained men with a mean of 4.2 years experience and in 22 resistance-trained males,
respectively (3, 77). This inconsistency in results suggests that further research is
required before a definitive conclusion can be made.
Duncan, et al (23) conducted a double-blind, randomized crossover study
involving 9 males and 2 females with specific experience in performing resistance
exercise and were actively participating in greater than ten hours per week of
programmed strength and conditioning activities. Each subject was provided placebo
or 5 mg/kg of caffeine and tested in randomized order for number of repetitions to
failure, rating of perceived exertion (RPE) and perception of muscle pain during
resistance exercise (23). All subjects were competent in techniques performed in the
study, including bench press, deadlift, prone row, and back squat exercises (23).
Subjects were asked to refrain from vigorous exercise and to maintain normal dietary
patterns for the 48 hours prior to testing, and were asked to cease caffeine use from
6:00 pm the night before testing (23). In the caffeinated condition, subjects had a
lower RPE and muscle pain perception compared to the placebo condition. This study
determined that caffeine ingestion did not enhance performance in number of
repetitions, but did reduce perception of exertion and muscle pain (23).
A power trial performed by Doherty et al evaluated the effect of moderate-dose
caffeine on performance during high-intensity cycling (21). Eleven trained male
cyclists recruited from local cycling clubs were recruited for this double-blind,
randomized, crossover study where they received caffeine equivalent to 5 mg/kg BW
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or placebo and participated in a ramp test designed to exhaust participants in 10-12
minutes (21). Mean power output was significantly greater in the caffeine treated
group compared to placebo. Additionally, blood lactate was significantly higher in the
caffeine treatment group compared to placebo (21). This was hypothesized to be one
of the mechanisms that allowed the caffeine treatment group to perform at a higher
intensity than the placebo group (21).
Lorino et al. (46) evaluated the effect of caffeine on agility, another measure of
anaerobic performance. Agility is a skill that involves speed and reaction time as well
as other performance skills. In this study, 17 males consumed placebo or 6 mg/kg BW
caffeine in randomized order and performed a proagility run test and 30-second
Wingate test (a common test used for anaerobic power) (46). Results showed that
caffeine did not improve agility or power output in young, recreationally active males
who are not habituated to caffeine (46). In a similar manner, Bell et al. (8) examined
the impact of caffeine alone and combined with ephedrine in 16 untrained males
through use of a 30-second Wingate test. Like the study by Lorino et al, caffeine did
not improve anaerobic power, suggesting that caffeine does not improve the anaerobic
parameters of power and agility in recreationally trained athletes (8, 46).
Another double-blind, randomized, crossover study by Astorino et al (3),
evaluated 22 resistance-trained men who completed total-body resistance training a
minimum of two days per week. Recruited subjects ingested either 6 mg/kg BW of
caffeine or a placebo and performed repetitions to failure on both the barbell bench
press and leg press using 60% of their determined maximal lifting ability (1RM) (3).
Subjects refrained from caffeine intake for 48 hours and strenuous exercise for 24
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hours before each visit. There was no significant effect of caffeine on muscular
strength or endurance, determined as complete number of repetitions to failure, in
subjects when consuming caffeine when compared to placebo when a dosage of 6
mg/kg BW was used (3).
In another crossover study, twenty elite male athletes performed knee extensor
and flexor exercises (39). Subjects recruited were intercollegiate Division I varsity
American football team members. Exclusion criteria included high daily caffeine
consumption (defined as >100 mg/day) or lacking sufficient weight training
experience (defined as less than two years). Subjects were required to abstain from
exercise for 48 hours and from caffeine for one week prior to testing (39). A
significant increase in muscular power was noted in subjects when they ingested
capsules containing 7 mg/kg BW, compared to placebo (39).
Woolf, et al (78) performed a randomized crossover study examining the effect
of 5 mg/kg BW of caffeine in 17 collegiate football athletes. All participants recruited
were considered low caffeine users, with a reported average intake of 16+20 mg/day
(78). Participants ingested either caffeine or placebo beverage with a small meal and
completed three exercise tests: a 40-yard dash, 20-yard shuttle, and bench press until
fatigue using either 185 or 225 pounds, with the lower weight used for participants
who were unable to bench 225 pounds (78). No differences were found between
treatments for any of the three exercise tests; however, 59% of the participants
improved in performance with caffeine with the bench press and 40-yard dash (78).
Unlike other studies, which use 60% of participant’s calculated 1RM for testing
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purposes, this study chose a standardized weight, regardless of each subject’s
individual ability (3, 78).
In a study by Bloms et al, 25 male and female NCAA Division I collegiate
athletes participating in 8-20 hours of training per week were recruited to asses squat
jump (SJ) height following ingestion of caffeine equivalent to 6 mg/kg BW (13).
Caffeine ingestion had a positive significant effect (p=0.001) in SJ height, with an
improvement of 5.4+6.5% (13). Of the 16 males enrolled, 9 were identified as
responders during the SJ; 78% (7/9) of these subjects who responded to caffeine were
identified as habitual consumers (13). Bloms et al. concluded that a dosage of 5 mg/kg
of caffeine may positively impact performance in ballistic tasks such as the vertical
jump (13). However, the authors note that all subjects recruited were Division I
athletes, and that results may not be generalizable to lower-level athletes and the
general population (13).
Plaskett, et al performed a randomized, double-blind, repeated measures
experiment evaluating a dose of 6 mg/kg in 15 males (61). Subjects performed
repeated submaximal contractions of the right quadriceps one hour after ingestion of
either caffeine, placebo, or no capsule (61). Results of the study concluded that
caffeine increased muscular endurance in repeated submaximal isometric contractions
in the quadriceps (61). In this study, all subjects were non-habitual caffeine users,
defined as those who reportedly consumed less than 200 mg of caffeine/wk (61).
Furthermore, this study did not define the current resistance training status of its
participants (61).
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Duncan, et al evaluated bench press repetitions to failure in 13 moderately
resistance trained men (22). Participants in his study consumed 5 mg/kg caffeine or
placebo and performed bench press repetitions to failure using 60% 1RM (22).
Participants completed significantly more repetitions to failure and lifted significantly
greater weight with the caffeine treatment compared to placebo (22). However, RPE
was not significantly different between groups (22). Subjects recruited were all active
participants in University team sports, including rugby, football, and basketball, and
have been competing in their sport for a mean time of 10.4+2.3 years (22). As a result,
the results of this study are likely not generalizable to a broader audience, such as
recreational athletes.
Discrepancies in the literature exist regarding caffeine’s potential ergogenic
effect on anaerobic performance. However, this variability can be due to a number of
factors, including testing procedures, caffeine administration dose, subject caffeine
habituation, and subject strength training experience. Previous studies have provided
subjects with varying amounts of caffeine using similar crossover designs (3, 23, 39,
78). While the amount of caffeine provided varied based on the study, the method of
determining the amount was based on a standard equation of milligrams per kilogram
of actual subject (mg/kg body weight) (3, 23, 39). Results from the studies performed
by Duncan et al (23), Astorino et al (3), and Jacobson et al (39) suggest that 7 mg/kg
of BW is an effective dosage to experience a significant change in performance in
strength training exercises. As a result, our proposed study also utilizes a caffeine
dosage of 7 mg/kg BW.
Conclusions
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As previously stated, muscle endurance is commonly measured using
repetitions to failure with weights equivalent to a percentage of an individual’s 1RM
(17). Currently, information published in the literature on resistance training variables
is insufficient in terms of concluding whether or not caffeine has an ergogenic effect
on resistance training variables, such as muscle endurance, in recreationally trained
athletes, as a majority of the literature recruits participants at the collegiate athletic or
above level. Additionally, to our knowledge, there is limited research comparing
caffeine’s effects for resistance training between habitual and non-habitual caffeine
users. Therefore, in our study, we ask recreationally trained athletes to perform a
combination of resistance exercises incorporating large muscle groups in both upper
and lower body – bench press repetition to failure, squat repetitions to failure,
isometric force plate, and vertical jump - while ingesting a dose of caffeine equivalent
to 7 mg/kg BW.
Currently, research of the potential effect of caffeine on muscular endurance
has been performed on subjects demonstrating elite athletic ability (3, 39). Less
research has been performed on the impact of acute caffeine ingestion on strength and
endurance in the average individual who participates in light to moderate consistent
physical activity. Our primary hypothesis is that acute caffeine ingestion in the amount
of 7 mg/kg BW will increase the number of bench press repetitions to failure
compared to placebo ingestion in college age, recreational male athletes. Our
secondary hypothesis is that acute ingestion of caffeine will also increase the number
of squat repetitions to failure, increase the amount of force generated from a vertical
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jump and isometric squat exercise, and decrease rating of perceived exertion at the
time of testing, when compared to placebo ingestion.
Furthermore, previous studies have not taken body composition into
consideration (3, 23, 39). Our exploratory hypothesis is that subjects with lower body
fat percentage will demonstrate a significant increase in repetitions to failure in bench
press and squat exercises when ingesting caffeine when compared to subjects with a
higher body fat percentage. To determine this, body fat percentage will be collected
prior to testing. As an additional exploratory hypothesis, we believe rating of
perceived exertion will be decreased in subjects when ingesting caffeine
supplementation compared to placebo.
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Appendix 2: Consent Form
Subject Consent Form for Research
The University of Rhode Island
Department of Kinesiology
Kingston, RI 02881
The Effect of Caffeine on Muscular Endurance and
Power in College Male Athletes
You are being invited to take part in a research project described below. The
researcher will explain the project to you in detail. You should feel free to ask
questions. If you have more questions later, Dr. Kathleen Melanson, the person
mainly responsible for this study, (Phone 401-874-4477); Dr. Disa Hatfield, a coinvestigator in the Kinesiology department, (Phone 401-874-5183); or Dr. Kelly
Matson, a co-investigator in the Pharmacy department, (Phone 401-874-5811), will
discuss them with you. You must be at least 18 years old to be in this research project.
Description of the project:
You have been asked to take part in the study that tests the potential effect of a high
caffeine dosage on muscular endurance and power.
What will be done:
1. Height, weight, and 1-repetition maximum (the maximum amount of weight that
can be moved with one repetition) estimates will be taken.
2. The study will consist of two test days, one week apart, where you will perform
repetitions with weights equal to approximately 60% of your respective 1-repetition
maximum until failure in two exercises (Smith machine squat and bench press).
3. 24-hours prior to the test day, subjects are asked to abstain from consuming
caffeine-containing products.
4. On the test day, a capsule(s) containing either a placebo or a pre-made caffeine
supplement equal to 7 milligrams per kilogram of body weight will be provided to the
subject for consumption (for example, if a subject weighs 75 kilograms, they will
ingest capsules equivalent to 525 milligrams of caffeine). Twelve fluid ounces of
water will be provided to aid in pill ingestion.
5. Subjects will remain stationary to allow absorption for one hour after consuming the
pill(s).
6. A brief questionnaire will be provided to be completed throughout the testing
process.
7. The following tests will be performed:
• Bench press to failure using weight equivalent to 60% of the 1-repetition
maximum weight (calculated from the bench press value obtained during the
first visit)
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Smith machine squat to failure using weight equivalent to 60% of the 1repetition maximum weight (calculated from the leg press value obtained
during the first visit)
• Force plate test
• Vertical jump test
8. Subjects are to consistently keep a log for three days following the test procedure.
No dietary restrictions will be in place at this time; however, 24-hours prior to the
second test day, subjects will be asked to abstain from caffeine-containing products.
9. One week later, subjects will return to perform the same procedure, consuming the
alternative capsule(s). Throughout the study, both the subject and the researchers will
be unaware as to whether you have consumed the caffeine capsule(s) or the placebo
until after all testing has been completed.
•

Risks or discomfort:
Caffeine is a stimulant, and this test involves the consumption of a significant dosage
of caffeine. While the amount consumed is well within the safe limit, there is a risk of:
increased blood pressure, reduced control of fine motor movements, and risk of
insomnia. Risk is greater in non-habitual consumers. Caffeine withdrawal can also
produce headache, fatigue, and decreased alertness. In addition, caffeine has been used
as a diuretic, which can be detrimental to athletes performing in long-term endurance
events.
In addition to caffeine use, there is risk of injury in performing any form of strength
training exercises. This study requires testing for 1-repetition maximum and
performing repetitions to failure in different muscle groups.
The amount of caffeine used in this study is well within the safe limits of consumption
for healthy, adult males. In addition, many previous studies testing the effect of
caffeine on healthy adults during physical activity have incorporated caffeine with
doses at and exceeding the dosage used in this study (7 milligrams of caffeine per
kilogram of body weight). In order to maintain safety of all subjects, the following
criteria warrants exclusion from the study: those with diagnosed high blood pressure,
known or suspected allergies/negative reactions to caffeine, and/or known or
suspected heart conditions.
Benefits of this study:
Although there will be no direct benefit to you for taking part in this study, the
researcher may learn more about caffeine supplementation in regards to strength
athletes. Currently, there is significant data to demonstrate the benefit of caffeine
consumption prior to cardiorespiratory endurance activities (running, cycling).
However, little data is currently available in regards to muscular strength/endurance.
Confidentiality:
Your participation in this study is strictly confidential. None of the results or collected
data will identify you by name. All records will be stored in a locked cabinet and
viewed solely within the Energy Balance Lab located in Fogarty Hall. Data entered in
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any computer programs will not contain information identifiable back to you. Please
note, all data is subject to inspection by federal, state, and local agencies, such as the
Food and Drug Administration (FDA).
In case there is any injury to the subject: (If applicable)
In the event of an injury during the testing process, the URI emergency medical
services will be contacted at (401)-874-5255. If this study causes you any injury, you
should write or call the office of the Vice President for Research, 70 Lower College
Road, University of Rhode Island, Kingston, Rhode Island, telephone: (401) 8744328.
Decision to quit at any time:
Participation in this study is up to you. You are in no way required to participate. If
you decide to take part in the study, you may quit at any time. Whatever you decide
will in no way be recorded, penalize you, affect enrollment status and/or grades. If you
wish to quit, you simply inform the lab (Fogarty 205, phone 401-874-2067) of your
decision.
Rights and Complaints:
If you are not satisfied with the way this study is performed, you may discuss your
complaints with Dr. Kathleen Melanson (401-874-4477), Dr. Disa Hatfield (401-8745183), or Dr. Kelly Matson (401-874-5811) anonymously, if you choose. In addition,
you may contact the office of the Vice President for Research, 70 Lower College
Road, Suite 2, University of Rhode Island, Kingston, Rhode Island, telephone: (401)
874-4328.
You have read the Consent Form. Your questions have been answered. Your
signature on this form means that you understand the information and you agree to
participate in this study.
I,
____________________________________________________________________
residing at
________________________________________________(zip)_________
telephone _________________________ age _________ (date of birth)
____________
agree to participate in this research project.

____________________________
Signature of subject

____________________________
Signature of Researcher
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____________________________
Typed/printed Name

____________________________
Typed/printed Name

_______________________
Date

_____________________
Date

Please sign both consent forms, keeping one for yourself.
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Appendix 3: Study Timeline

50

Appendix 4: Test Day Timeline
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Appendix 5: Pre-Screening Questionnaire
Pre-Screening Questionnaire
How would you describe your weightlifting routine?
0-1
2-3
4-5
5+
(days per week)
How long have you consistently participated in weight-bearing exercise?
<1 month
1-3 months 4-5 months 6-12 months +1 year
Are bench-press exercises incorporated in your typical weight-bearing routine?
yes
no
Are leg-press exercises incorporated in your typical weight-bearing routine?
yes
no
How would you describe your typical coffee intake (caffeinated)?
0
1
2
3
4
5+
(8 fl oz cups per day)
How would you describe your typical soda intake (caffeinated)?
0
1
2
3
4
5+
(8 fl oz cups per day)
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Appendix 6: Personal Health History Questionnaire
Personal Health History Questionnaire
Please complete this as accurately and completely as possible. If you would like
clarification on any question, please feel free to ask.
Name: ____________________________________ Age: ________

Gender

_________
Mailing address: _______________________________________________________
Phone number: _____________________________ Today’s date: ________________
Email address: _____________________________
Approximate weight: _____________________Approximate height:
______________
Ethnic Background (circle one)
•
•
•
•
•

African-American
Asian-American
Caucasian
Hispanic-American
Other _____________________________

General Medical History

Circle One

Do you currently have any medical complaints?

Yes

No

(please specify) ________________________________________________________
Do you take any prescribed or over-the-counter medication?

Yes

No

(please specify) ________________________________________________________
Dietary History
Please list any food allergies, intolerances or specific foods you avoid
_____________________________________________________________________
Do you experience caffeine withdrawal symptoms if you do not consume it in the
morning. (i.e., headache)?
__________________________________________________
Are you able to abstain from alcohol consumption for several days in a row?
____________________________________________________________________
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Please describe your diet history. Make sure to specify if you are or have been
vegetarian, if you are or have been on a self-prescribed or medical-prescribed special
diet, or if you have participated in bingeing, crash diets, cyclic dieting, or were
anorexic and/or bulimic:
_________________________________________________________
The following questions address body weight history.
What is the length of time you have maintained your present weight? _____________
How much would you like to weigh? ________________________
How many times has your weight fluctuated by at least 5 lbs in the last year? _______
Please describe any long-term weight changes you have experienced (e.g., lost 50 lb.
in 1995):______________________________________________________________
How would you describe the typical weight of your parents over the last few years?
Under-weight Just right Over-weight

Obese Unknown

Your Mother

O

O

O

O

O

Your Father

O

O

O

O

O

General History: Have you had or do you have:
Adrenal disease

Yes

No

Hypoglycemia (low blood sugar)

Yes

No

Seizures

Yes

No

Kidney or bladder problems

Yes

No

Stomach ulcers

Yes

No

Diabetes

Yes

No

Family history of diabetes

Yes

No

Thyroid Diseases

Yes

No

Any chronic illness that might cause weight loss

Yes

No

Atrial Fibrillation (irregular heart rate)

Yes

No

Tachycardia (fast heart rate)

Yes

No

Other

Yes

No

Explain any Yes responses:

54

_______________________________________________
Do you have any close blood relatives have or had type 2 diabetes (parents,
grandparents, siblings, aunts or uncles)?

Yes

No

Do you have any close blood relatives have or had heart disease? Yes
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No

Appendix 7: Caffeine Frequency Questionnaire
Subject ID: ______________________

Date: ___________________

CAFFEINE FREQUENCY QUESTIONNAIRE (CFQ)
Please answer the following questions as completely and honestly as you can. This
information is STRICTLY CONFIDENTIAL - do not write your name anywhere on
this page.
Select the box next to each item that best describes your usual intake. Consider intake
over the course of the past calendar year.

Never

Monthly

Brewed, generic
Brewed, decaf
COFFEE

Espresso
Espresso decaf

Brewed
Snapple
TEAS

Nestea
Arizona Iced
Coca-Cola
Diet Coca-Cola

Dr. Pepper
Diet Dr. Pepper
SOFT
DRINKS

Pepsi
Diet Pepsi
Root Beer
Diet Root beer
Sierra Mist
Sprite
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Weekly

1
serving/
day

2
serving
/day

3+
serving/
day

Never

Monthly

Monster
Full Throttle
ENERGY
DRINKS

Red Bull
Vitamin Water
Amp
5 Hour energy

FROZEN
DESSERTS

Ben & Jerry’s
Coffee ice cream
Starbucks coffee
ice cream
Hershey’s
chocolate

CHOCOLATE

Hershey's Dark
chocolate
Hershey's kisses
Hot cocoa (5 oz)
Vivarin
NoDoz
Excedrin

MEDICATIONS

Vanquish
Anacin
Dristan
Dexatrim
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Weekly

1
2
3+
serving serving serving
/day
/day
/day

Appendix 8: Borg CR-10 Scale of Perceived Exertion
Borg CR-10 Scale of Perceived Exertion

0

Nothing at all

0.3
0.5

Extremely weak

Just noticeable

0.7
1

Very weak

1.5
2

Weak

Light

2.5
3

Moderate

4
5

Strong

Heavy

6
7

Very strong

8
9
10

Extremely strong

“Maximal”

Absolute maximum

Highest possible

11

58

Appendix 9: Additional Tables and Figures
Table 2: Correlations Between Exercise Performance with Caffeine Based on
Lean Body Mass and Self-Reported Habitual Consumption
Bench Press repetitions
Caffeine

Squat repetitions

∆ Treatments

R

p

R

mg/kg LBM

.020

.924

.065

Habitual
consumption

.186

.384

.193

p

Caffeine

∆ Treatments

R

p

R

p

.762

-.031

.887

.297

.159

.366

-.016

.939

.003

.989

Pearson correlations used. No significant correlations found. Lean body mass calculated by subtracting
fat mass from total body mass.
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Table 3: Mean±SD of RPE Before and After Bench Press and Smith Machine
Squat Tests with Caffeine and Placebo Treatments
Caffeine

Placebo

Pre

Post

Pre

Post

p

Bench Press
(n=21*)

2.3±1.9

5.5±1.9

2.6±1.6

5.9±1.9

0.360

Squat
(n=23)

1.5±1.3

5.9±1.6

1.9±1.5

6.1±2.1

0.196

2x2 Repeated Measures ANOVA used. No significance between treatments in either bench press or
squat.
*2 subjects omitted due to missing data
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Figure 4: Relationship Between 1RM Squat and 1RM Bench
350

1RM BENCH

300
y = 0.762x + 10.854
R² = 0.57253

250

200

150

100
100

150

200

250
1RM SQUAT
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300

350

400

Figure 5: Proportion of Subjects Receiving Varying Dosages of Caffeine Based on
Lean Body Mass
Mean (±SD) dosage received based on total body mass (mg/kg): 7.0±0.1
Mean (±SD) dosage received based on lean body mass (mg/kg): 8.3±0.7

9.0+
26%
7.0 to 7.9
39%

8.0 to 8.9
35%
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Figure 6: Difference in Individual Number of Bench Press Repetitions to Failure
in Subjects Identified as Low Caffeine Consumers
Low caffeine consumer defined as ≤8oz of caffeine containing product/day, as
determined by self-reported caffeine frequency. (n=15)
6
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Figure 7: Difference in Individual Number of Bench Press Repetitions to Failure
in Subjects Identified as High Caffeine Consumers
High caffeine consumer defined as >8oz of caffeine containing product/day, as
determined by self-reported caffeine frequency. (n=8)
6
5

Difference in Repetitions
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Figure 8: Difference in Individual Number of Smith Machine Squat Repetitions
to Failure in Subjects Identified as Low Caffeine Consumers
Low caffeine consumer defined as ≤8oz of caffeine containing product/day, as
determined by self-reported caffeine frequency. (n=15)
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Figure 9: Difference in Individual Number of Smith Machine Squat Repetitions
to Failure in Subjects Identified as High Caffeine Consumers
High caffeine consumer defined as >8oz of caffeine containing product/day, as
determined by self-reported caffeine frequency. (n=8)
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Appendix 10: Flyer
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